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Elastosis perforans serpiginosa (EPS) is an unusual perforating disorder characterized by extrusion of
altered elastic ﬁbers through the epidermis. Clinically, it presents as keratotic papules with a tendency
for serpiginous or annular distribution that most commonly involves the sides of the neck and the back.
However, involvement of the penis has rarely been reported. We present a case of EPS involving the neck,
axilla, and glans penis in a 42-year-old man who had received long-term D-penicillamine treatment for
Wilson disease. Skin biopsy revealed perforating channels containing numerous altered elastic ﬁbers,
with a characteristic “bramble brush” or “lumpy-bumpy” appearance as demonstrated by an elastin stain.
The latter is thought to be pathognomonic for penicillamine-induced degenerative elastosis. These
degenerative changes occurring in glans penis have rarely been described in the literature. Prompt
recognition of the rare presentation could lead to early discontinuation of the offending drug, to prevent
further sequelae.
Copyright  2013, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction Case reportElastosis perforans serpiginosa (EPS) is recognized as one of the
four classical primary perforating disorders, along with reactive
perforating collagenosis, perforating folliculitis, and Kyrle disease.
It is known to occur in association with other systemic diseases,
particularly inherited connective tissue disorders such as Ehlers-
Danlos syndrome, osteogenesis imperfecta, pseudoxanthoma
elasticum, or Marfan syndrome.1 It is also a well-recognized po-
tential complication of long-term D-penicillamine therapy. Here, we
present a case illustrating the typical histological ﬁndings of D-
penicillamine-induced EPS, including characteristic “bramble
brush” or “lumpy-bumpy” alterations of elastic ﬁbers, with an
extremely rare clinical presentation involving the glans penis. The
skin eruptions of our case developed on the glans penis initially
without typical annular or serpiginous conﬁguration, which could
make it difﬁcult to diagnosis accurately. Our case highlights that
EPS should be considered as a differential diagnosis at this site.y have no ﬁnancial or non-
tter or materials discussed in
gy, Changhua Christian Hos-
nghua County 500, Taiwan.
iwanese Dermatological AssociatioA 42-year-old male patient presented to our dermatology depart-
ment with a history of progressive, slightly itchy skin eruptions
initially on the glans penis, then spreading to neck and axilla during
the previous 2months. He had been diagnosed withWilson disease
when he was 26 years old and had received long-term treatment
with D-penicillamine (600 mg, three-times daily) for more than 16
years. Physical examination revealed erythematous to dusky red
keratotic papules, that had a tendency to coalesce into annular and
serpiginous plaques, with a central clearing on both sides of the
neck and axillary areas (Figure 1A and B). There were also several
discrete erythematous papules with central keratotic plugs on the
glans penis (Figure 1C and D). Skin biopsy from the axilla and glans
penis revealed a localized area of irregular acanthosis with broad-
ened rete ridges and epidermal invagination surrounding baso-
philic inﬂammatory debris and eosinophilic material that formed
conﬁguring perforating channels (Figure 2A and B). At a higher
magniﬁcation, degenerated cells, mixed inﬂammatory cells, and
inﬂammatory debris with an accumulation of eosinophilic frag-
mented ﬁbers at the base of channels, could be seen in the perfo-
rating channels (Figure 2C and D). An elastin stain showed
numerous irregular, coarse, and fragmented elastic ﬁbers within
the channels (Figure 2E). At a higher magniﬁcation, multiplen. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 (A) Erythematous to dusky red keratotic papules coalescing to form annular or serpiginous plaques with a central clearing on both sides of the neck occurred in this 42-
year-old man. The patient had been on long-term treatment with D-penicillamine for Wilson disease; (B) serpiginous plaques with a central clearing and atrophy near the axilla
were observed in the same patient; and (C, D) several erythematous papules with central keratotic plugs were seen on the glans penis of the same patient (arrow).
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irregular elastic ﬁbers, producing a characteristic “bramble brush”
or “lumpy-bumpy” appearance, were observed (Figure 2F).
According to the clinical observations and histological ﬁndings,
a diagnosis of D-penicillamine-induced EPS was made. We initially
administered topical tazarotene gel, but the patient could not
tolerate the side effects that included peeling and irritation. He was
further treated with cryotherapy. Although some of the previous
lesions showed partial regression after treatment, some continued
to progress. After consulting with the patient’s neurologist, we
substituted trientine dihydrochloride for D-penicillamine to control
the symptoms of Wilson disease. The skin lesions stopped pro-
gressing, leaving central atrophic scars during a 1-year follow-up
(Figure 3A and B).
Discussion
EPS is a rare perforating dermatosis characterized by trans-
epidermal elimination of altered elastic ﬁbers. These conditions are
characterized by the clinical presentation of hyperkeratotic papules
that occur in a serpiginous arrangement, with the microscopic
characteristic of transepidermal elimination of abnormal elastic
ﬁbers. It is a rare disorder that mainly affects adolescents or young
adults, with a 4:1 male predominance.2 It has traditionally been
classiﬁed into the following three subtypes: idiopathic; secondary
to treatment with D-penicillamine; or associated with other sys-
temic, inherited, ﬁbrous tissue abnormalities such as Down syn-
drome, Marfan syndrome, acrogeria, pseudoxanthoma elasticum,
osteogenesis imperfecta, Rothmund-Thomson syndrome, Ehlers-
Danlos syndrome, or scleroderma. Once the diagnosis of EPS is
made, the clinician should investigate the possibility of comorbid
states or penicillamine therapy. Some experts recommend
ophthalmologic examination and cardiac echocardiography,whereas others defer such investigations beyond a thorough pa-
tient history and physical examination.1
The exact cause of EPS is unknown, but it has been suggested
that the primary abnormality is possibly in the dermal elastin,
which provokes a cellular response leading to the extrusion of
abnormal elastic tissue.3 Fujimoto et al demonstrated that elastin
could be a potent inducer of migration and terminal differentiation
of cultured keratinocytes, mediated by the 67 kDa elastin receptor.4
The receptor is abundantly expressed in the active peripheral
keratotic area of EPS and appears to be related to the elastic ﬁber
content in the dermal material.5 It has been postulated that the
elastin-keratinocyte interaction, mediated by the elastin receptors,
plays an important role in the transepidermal elimination of
elastin, inducing EPS.
D-Penicillamine has been used as one of chelating agents and
disease modifying antirheumatic drugs in the treatment of Wilson
disease, cystinuria, rheumatoid arthritis, and scleroderma.6 The
most common adverse effects of D-penicillamine are cutaneous,
occurring in approximately 25e50% of patients. These adverse ef-
fects can be classiﬁed into four groups based on the induction
mechanism, including: (1) interference with collagen and elastin
such as pseudoxanthoma elasticum, cutis laxa, and mucosal elas-
tosis; (2) acute sensitivity reactions such as urticaria and exan-
thematous drug-induced eruption; (3) autoimmune mechanisms
such as bullous and lupus-like reactions; and (4) miscellaneous
dermatoses that result from undeﬁned mechanisms.7,8 The postu-
lated mechanisms relevant to collagen and elastic ﬁbers include:
(1) direct inhibition of collagen synthesis, a well-known effect of
D-penicillamine for the treatment of scleroderma that further in-
terferes with elastic ﬁber cross-linking; and (2) copper deﬁciency
secondary to D-penicillamine treatment at higher doses, that im-
pairs the lysyl oxidase activity on elastic ﬁber desmosine cross-
linking, a crucial process in ﬁber stabilization.7,9 Accordingly, the
Figure 2 (A) A skin biopsy from the axilla showed irregular acanthosis with broadened rete ridges, epidermal invagination surrounding basophilic inﬂammatory debris and
eosinophilic fragmented ﬁbers that formed perforating channels [hematoxylin and eosin (H and E, 40)]; (B) another skin biopsy taken from the glans penis indicated a localized
area of acanthosis surrounding the perforating channels, through which inﬂammatory debris and eosinophilic fragmented ﬁbers were being eliminated [hematoxylin and eosin (H
and E, 40)]; (C) the perforating channels of an axillary skin biopsy containing degenerated cell debris, mixed inﬂammatory cells, and inﬂammatory debris, with an accumulation of
eosinophilic fragmented ﬁbers at the base of channels [hematoxylin and eosin (H and E, 40)]; (D) the perforating channels of a penile biopsy containing a mixed inﬂammatory
inﬁltrate of predominantly neutrophils, cell debris, and fragmented ﬁbers at the base of the channels [hematoxylin and eosin (H and E, 40)]; (E) numerous irregular thickened and
fragmented elastic ﬁbers within the channels were revealed by an elastin stain (orcein stain, 100); and (F) perpendicular budding from the surface of the irregular elastic ﬁbers
formed a serrated border (arrow) giving a characteristic “bramble brush” or “lumpy-bumpy” appearance at a higher magniﬁcation (orcein stain, 400).
Y.-N. Chuang et al. / Dermatologica Sinica 32 (2014) 93e96 95accumulation of abnormal elastic ﬁbers could provoke a foreign
body reaction, by inducing elastin-keratinocyte interactions, and
subsequently transepidermal extrusion of abnormal elastic ﬁbers
developed, which caused the hallmark indication of EPS. D-Peni-
cillamine-induced EPS is almost exclusively associated with long-
term therapy for Wilson disease and cystinuria, probably because
these drug effects require prolonged administration of D-penicil-
lamine at high dose (1 g daily for more than 5 years).10 The cu-
mulative dosage and duration of D-penicillamine in our patient is
1800 mg daily for about 16 years.
Previous reports of D-penicillamine-induced EPS showed that it
could coexist with other cutaneous adverse effects related to elastic
ﬁber alteration, such as pseudoxanthoma elasticum,11,12 cutis
laxa,7,13,14 and mucosal elastosis.15,16 Some authors have suggested
that dermatoses should be considered as different expressions of
the same degenerative process and reclassiﬁed as one entity,
“penicillamine-induced degenerative dermatosis”.17 Moreover, the
D-penicillamine-induced elastic ﬁber alteration yields a peculiar
histopathologic feature e serrated appearance of elastic ﬁbers dueto perpendicular budding from their surface, giving a “bramble
brush” or “lumpy-bumpy” appearance3,18 e as demonstrated in our
case. This distinct degenerative elastolytic change could be seen in
patients with D-penicillamine-induced degenerative dermatosis.
Similar elastic ﬁber changes have also been reported to occur in
nonlesional skin,3 artery,19 upper respiratory tract,20 and lung.21
Such widespread changes may suggest ongoing, potentially
serious systemic effects caused by elastic ﬁber damage.
Numerous treatment methods for EPS have been described,
although there is no “gold standard” therapy. Anecdotally reported
effective therapies include oral isotretinoin,22 topical tazarotene,23
imiquimod,24 narrow-band ultraviolet B, calcipotriene,25 cryo-
therapy,26 and laser ablation.27 D-Penicillamine therapy to treat
Wilson disease can be substituted by the administration of alter-
native medications such as zinc salts, which block the intestinal
absorption of copper, and trientine dihydrochloride, another cop-
per chelator with less toxicity.16,28 In the patient of the present case,
discontinuation of penicillamine therapy stopped the progression
of EPS. However, multiple case reports have described the abrupt
Figure 3 (A) Previous skin lesions on side of the neck stopped progressing, leaving central atrophic scars 1-year after discontinuation of D-penicillamine use; and (B) the skin lesions
on the glans penis left several depressed scars with slightly elevated erythematous borders.
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cillamine therapy.11,13,15 These events are probably related to the
cumulative dose and slow clearance of the drug, with the remain-
ing effects observed on the elastic tissue.13
To the best of our knowledge, glans penis is an extremely rare site
that develops EPS. Roest andRatnavel reported the case of a 44-year-
old man with D-penicillamine-induced EPS on the glans penis with
cystinuria.29 It presented as a single, isolated erythematous scarring
plaque with a pale depressed center on the glans penis that devel-
oped after recurrent episodes of asymptomatic ulceration, without
coexistent EPS at other sites. This ﬁnding was different from that in
our patient. As mentioned above, D-penicillamine-induced degen-
erative changes of elastic ﬁbers could be found in the skin, mucosa,
and other visceral organs; therefore, it is reasonable that similar
changes can occur in the glans penis to cause penile EPS.
In conclusion, we present a case of EPS caused by long-term
administration of D-penicillamine with the involvement of glans
penis. The atypical presentation and rarity of the disease could
cause delayed diagnoses ormisdiagnoses. This disease is important,
as it represents a degenerative process induced by D-penicillamine
and probably represents only the tip of the iceberg because of the
potential involvement of other nonlesional skin and visceral or-
gans. Prompt recognition of these adverse cutaneous effects and
discontinuation of the drug may be necessary to prevent the
possible occurrence of systemic sequelae.
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